- PROVIDERS
- LIFE SCIENCES
-
PATIENTS
It's About Time
View the Tempus vision.
- RESOURCES
- ABOUT US
Bringing the power of data and artificial intelligence to healthcare
the discovery of novel targets
the effectiveness of treatments
potentially life-saving clinical trials
multiple diseases earlier
We can assist pharmaceutical and biotech companies with better drug development.
Learn MoreWe have built a proprietary Platform to make data accessible and deploy AI at scale.
Learn MoreThrough our scientific publications and research projects, we are accelerating and transforming personalized patient care.
View All PublicationsThe expanded collaboration bolsters GSK’s data science and AI-driven R&D efforts, providing the company access to Tempus’ AI-enabled platform to support improved clinical trial design, speed up enrollment, and identify drug targets.
READ PRESS RELEASEKate Sasser, PhD, joined Tempus as its Chief Scientific Officer. Dr. Sasser is applying her extensive experience in translational research, precision medicine, data science, and drug discovery to bring personalized medicine solutions to Tempus’ life science collaborators, physicians, and patients.
READ PRESS RELEASETempus launches its multi-center study titled, “Electrocardiogram-based Artificial Intelligence-Assisted Detection of Heart Disease,” or ECG-AID, which aims to evaluate the impact of the company’s investigational, AI-enabled, predictive tests in cardiology and focuses on finding patients at high risk of developing atrial fibrillation (AFib) or any of seven structural heart diseases (SHD).
READ PRESS RELEASEThis is the future of healthcare.